Thyroid dysfunction induced by immune checkpoint inhibitors and tumor progression during neoadjuvant therapy of non‑small cell lung cancer: A case report and literature reviewXinyi Li, Luwen Shi, Xun Wang et al.|Oncology Letters|2023Cited by 6
Long-Term Survival of PD-1 Inhibitor Combined with Antiangiogenic Agents in a Patient with Pulmonary Sarcomatoid Carcinoma Complicated with Esophageal Cancer: A Case Resport and Literature ReviewShuyue Jiao, Hong Tang, Hui Zhu et al.|Research Square|2021Cited by 0
Thyroid dysfunction induced by immune checkpoint inhibitors and tumor progression in neoadjuvant therapy for Non-Small Cell Lung Cancer: a case report and literature reviewXinyi Li, Luwen Shi, Xun Wang et al.|Research Square|2022Cited by 0